Cyclacel Pharmaceuticals Explores Strategic Alternatives to Preserve Cash and Review Potential Transactions
Cyclacel Pharmaceuticals is exploring strategic alternatives to preserve cash, including a potential transaction with investor David Lazar.Quiver AI SummaryCyclacel Pharmaceuticals, Inc. has announced...
Cyclacel Pharmaceuticals Closes Transaction for Exercise of Existing Warrants and Issues New Warrants
Cyclacel Pharmaceuticals closed a warrant transaction, generating $2.1 million for working capital and corporate purposes.Quiver AI SummaryCyclacel Pharmaceuticals, Inc. has successfully completed a transaction...
Cyclacel Pharmaceuticals Announces Warrant Exercise Agreement to Raise Approximately $2.1 Million
Cyclacel Pharmaceuticals announces warrant exercise agreement, raising approximately $2.1 million for working capital and corporate purposes.Quiver AI SummaryCyclacel Pharmaceuticals, Inc. announced a...